Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Teva Pharma Ind.       

TEVA PHARMA IND.
Mes dernières consult.
Most popular
  Report  
 SummaryChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Financials (USD)
Sales 2018 19 600 M
EBIT 2018 -
Net income 2018 -
Debt 2018 -
Yield 2018 -
Sales 2019 19 500 M
EBIT 2019 -
Net income 2019 -
Debt 2019 -
Yield 2019 -
P/E ratio 2018 -
P/E ratio 2019
Capi. / Sales2018 1,21x
Capi. / Sales2019 1,22x
Capitalization 23 779 M
More Financials
Company
Teva Pharmaceutical Industries Ltd. is a global pharmaceutical company, which engages in development, production and marketing of drugs, generic drugs, over-the-counter drugs, active ingredients for the pharmaceutical industry (APIs) and therapeutic products.It operates through two segments:... 
Sector
Pharmaceuticals
Calendar
08/02 | 01:00pmEarnings Release
More about the company
Latest news on TEVA PHARMA IND.
07/20TEVA PHARMACEUTICAL INDUSTRIES : Highlights Key Milestones Achieved in the 2017 ..
AQ
07/19TEVA PHARMACEUTICAL INDUSTRIES : Announces Launch of a Generic Version of Uceris..
AQ
07/19TEVA PHARMACEUTICAL INDUSTRIES : Court allows closure of Teva's Ashdod plant
AQ
07/17PAXMAN PUBL : receives first order from Teva in Mexico for 17 scalp cooling syst..
AQ
07/17TEVA PHARMACEUTICAL INDUSTRIES : Highlights Key Milestones Achieved in the 2017 ..
BU
07/16TEVA PHARMACEUTICAL INDUSTRIES : Previous ArticleTeva Reports First Quarter 2018..
AQ
07/13TEVA PHARMACEUTICAL INDUSTRIES : FDA Recalls Several Medicines That Contain Vals..
DJ
07/13TEVA PHARMACEUTICAL INDUSTRIES : to Report Second Quarter 2018 Financial Results..
AQ
07/12TEVA PHARMACEUTICAL INDUSTRIES : Researchers at Teva Pharmaceutical Report New D..
AQ
07/12TEVA PHARMACEUTICAL INDUSTRIES : Mylan generic Copaxone price cut puzzles indust..
AQ
More news
Sector news : Pharmaceuticals - NEC
07/20GLAXOSMITHKLINE : considers splitting up the group - FT
RE
07/20PFIZER : Biosimilar of Amgen's Neupogen Approved for Sale in the U.S.
DJ
07/20BAYER : to Stop Selling Essure in U.S.
DJ
07/20GLAXOSMITHKLINE : considers splitting up the group
RE
07/20GLAXOSMITHKLINE : Mulls Separation of Consumer Division -- FT
DJ
More sector news : Pharmaceuticals - NEC
Chart TEVA PHARMA IND.
Duration : Period :
Teva Pharma Ind. Technical Analysis Chart | 4-Traders
Income Statement Evolution
Consensus
 
Mean consensus OUTPERFORM
Number of Analysts 1
Average target price 19,5 $
Spread / Average Target -15%
Managers
NameTitle
Kåre Schultz President, Chief Executive Officer & Director
Sol J. Barer Chairman
Carlo de Notaristefani Executive Vice President-Global Operations
Michael McClellan Chief Financial Officer & Executive Vice President
Amir Elstein Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
TEVA PHARMA IND.0.00%23 779
JOHNSON & JOHNSON-8.53%342 779
PFIZER3.98%220 295
NOVARTIS-1.75%206 001
ROCHE HOLDING LTD.-5.90%203 399
MERCK AND COMPANY11.09%169 328